Apixaban (Eliquis)

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
CardiacHematologic / ImmuneRenal / Urinary / Electrolytesneeds review

Apixaban (Eliquis)

ATI class: Anticoagulant / Direct factor Xa inhibitor

Action

  • ATI/source-folder candidate for Apixaban (Eliquis); verify mechanism against the source table before validation.

Therapeutic use

  • Review under Coagulation Disorders medication safety.

Nursing assessment

  • Assess bleeding, bruising, renal and hepatic function, weight, age-related dosing criteria, and adherence.
  • Review other anticoagulants, antiplatelets, NSAIDs, and strong CYP3A4/P-gp modifiers.
  • Assess thromboembolism risk if doses are missed or therapy is stopped.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Bleeding
  • GI bleeding
  • Intracranial hemorrhage
  • Anemia

Interactions

  • NSAIDs
  • Antiplatelets
  • Other anticoagulants
  • Strong CYP3A4 and P-gp inhibitors
  • Strong CYP3A4 and P-gp inducers

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Active major bleeding.
  • Use caution with renal impairment, hepatic impairment, older adults, low body weight, recent surgery, and neuraxial procedures.

Client teaching

  • Take consistently and do not skip or stop without provider direction.
  • Report bleeding, black stools, severe headache, weakness, falls, or blood in urine.
  • Tell all providers and dentists about anticoagulant use.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • No routine INR monitoring does not mean no bleeding risk.
  • Missed doses can increase clot risk.
  • Severe headache or neuro change is a bleeding emergency cue.

Medication classes

Anticoagulants

Source attribution

Google Drive source topic: Coagulation Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Anticoagulants

Reduces clot formation by interfering with the coagulation cascade.

ATI cuePrecaution
Active major bleeding.

ATI medication precaution concept.

ATI cueAdverse Effect
Anemia

ATI medication adverse effect concept.

ATI cueClass
Anticoagulant

ATI medication class concept.

ATI cueInteraction
Antiplatelets

ATI medication interaction concept.

ATI cueNursing Assessment
Assess bleeding, bruising, renal and hepatic function, weight, age-related dosing criteria, and adherence.

ATI medication nursing assessment concept.

ATI cueNursing Assessment
Assess thromboembolism risk if doses are missed or therapy is stopped.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Apixaban (Eliquis); verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueAdverse Effect
Bleeding

ATI medication adverse effect concept.

ATI cueClass
Direct factor Xa inhibitor

ATI medication class concept.

ATI cueAdverse Effect
GI bleeding

ATI medication adverse effect concept.

ATI cueAdverse Effect
Intracranial hemorrhage

ATI medication adverse effect concept.